logo
Amazon Q2 Earnings Beat Estimates, Shares Dip: ETFs in Focus

Amazon Q2 Earnings Beat Estimates, Shares Dip: ETFs in Focus

Globe and Mail01-08-2025
Amazon AMZN reported stronger-than-expected second-quarter 2025 results. The online behemoth outpaced earnings and revenue estimates but offered a muted third-quarter operating income guidance.
The guidance spooked investors who are eager to see Amazon's hefty investments in artificial intelligence pay off, pushing shares of AMZN down more than 8% in pre-market trading.
This has put ETFs with a substantial allocation to this online behemoth in focus. These include Global X PureCap MSCI Consumer Discretionary ETF GXPD, Fidelity MSCI Consumer Discretionary Index ETF FDIS, ProShares Online Retail ETF ONLN, Vanguard Consumer Discretionary ETF VCR and Consumer Discretionary Select Sector SPDR Fund XLY.
The e-commerce giant reported earnings per share of $1.68, outpacing the Zacks Consensus Estimate of $1.33 and the year-ago earnings of $1.23. Revenues grew 13% year over year to $167.7 billion and edged past the consensus estimate of $162.3 billion.
Amazon's advertising business was its fastest-growing division in the quarter. Ad revenues increased 23% year over year to $15.69 billion. Online store sales grew 11% to $61.48 billion, while Amazon's cloud computing business — Amazon Web Services ('AWS') — revenues soared 17.5% year over year to $30.9 billion (read: 5 ETFs to Profit From Amazon's Longest-Ever Prime Day Event).
Like other tech companies, Amazon has ramped up investments in data centers, chips and the power needed for AI workloads. The online giant has committed to spending up to $100 billion this year on AI as it races to build out data centers and software. It is also investing in its own computer chips and those developed by NVIDIA NVDA.
The world's largest online retailer expects revenues in the range of $174-$179.5 billion for the third quarter of 2025. The Zacks Consensus Estimate is pegged at $173.13 billion. Amazon expects operating income of $15.5-$20.5 billion in the third quarter, below analysts' expectations.
ETFs to Buy
Global X PureCap MSCI Consumer Discretionary ETF (GXPD)
Global X PureCap MSCI Consumer Discretionary ETF seeks to provide uncapped, market capitalization exposure to the Consumer Discretionary sector by tracking the MSCI USA Consumer Discretionary Index. It holds 50 stocks in its basket with Amazon occupying the top position at 38.3% of the assets. Global X PureCap MSCI Consumer Discretionary ETF has accumulated $0.5 million in its asset base since its debut last week and charges 0.15%.
Fidelity MSCI Consumer Discretionary Index ETF (FDIS)
Fidelity MSCI Consumer Discretionary Index ETF tracks the MSCI USA IMI Consumer Discretionary Index, holding 259 stocks in its basket. Of these, Amazon takes the top spot with a 24.2% share. Fidelity MSCI Consumer Discretionary Index ETF has amassed $1.8 billion in its asset base while trading in a good volume of around 86,000 shares a day on average. It charges 8 bps in annual fees from investors and currently has a Zacks ETF Rank #5 (Strong Sell) with a Medium risk outlook.
ProShares Online Retail ETF (ONLN)
ProShares Online Retail ETF offers exposure to companies that principally sell online or through other non-store channels and then zeroes in on the companies that reshape the retail space. It tracks the ProShares Online Retail Index, holding 19 stocks in its basket. Amazon is the top firm, accounting for 24% of the portfolio. ProShares Online Retail ETF has amassed $79 million in its asset base and currently trades in a moderate volume of around 8,000 shares a day on average. It charges 58 bps in annual fees from investors.
Vanguard Consumer Discretionary ETF (VCR)
Vanguard Consumer Discretionary ETF currently follows the MSCI US Investable Market Consumer Discretionary 25/50 Index and holds 296 stocks in its basket. Of these, Amazon occupies the top position, with a 23.9% allocation. Broadline Retail takes the largest share at 27%, while automobile manufacturers, restaurants and hotels, and resorts & cruise lines round off the next three spots. VCR charges investors 9 bps in annual fees, while volume is moderate at nearly 42,000 shares a day. The product has managed about $6.2 billion in its asset base and currently carries a Zacks ETF Rank #3 (Hold) with a Medium risk outlook (read: ETFs to Consider as Consumer Sentiment Improves in July).
Consumer Discretionary Select Sector SPDR Fund (XLY)
Consumer Discretionary Select Sector SPDR Fund offers exposure to the broad consumer discretionary space by tracking the Consumer Discretionary Select Sector Index. It is the largest and most popular product in this space, with AUM of nearly $22.5 billion and an average daily volume of around 5.1 million shares. Holding 51 securities in its basket, Amazon takes the top spot with 24.4% of the assets. Hotels, restaurants & leisure, broadline retail, specialty retail and automobiles are the top four sectors with double-digit exposure each. Consumer Discretionary Select Sector SPDR Fund charges 8 bps in annual fees and has a Zacks ETF Rank #3 with a Medium risk outlook.
Boost Your Portfolio with Our Top ETF Insights
Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox every week.
Don't miss out on this valuable resource. It's free!
Get it now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amazon.com, Inc. (AMZN): Free Stock Analysis Report
NVIDIA Corporation (NVDA): Free Stock Analysis Report
ProShares Online Retail ETF (ONLN): ETF Research Reports
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hallador Energy Company Schedules Second Quarter 2025 Conference Call for August 11, 2025 at 5:00 p.m. ET
Hallador Energy Company Schedules Second Quarter 2025 Conference Call for August 11, 2025 at 5:00 p.m. ET

Globe and Mail

time2 hours ago

  • Globe and Mail

Hallador Energy Company Schedules Second Quarter 2025 Conference Call for August 11, 2025 at 5:00 p.m. ET

TERRE HAUTE, Ind., July 28, 2025 (GLOBE NEWSWIRE) -- Hallador Energy Company (Nasdaq: HNRG) ('Hallador' or the 'Company'), will host a conference call on Monday, August 11, 2025, at 5:00 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2025. The Company's results will be reported in a press release prior to the call. Hallador's management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions prior to the call by emailing the Company's investor relations team, Elevate IR, at HNRG@ Date: Monday, August 11, 2025 Time: 5:00 p.m. Eastern time Dial-in registration link: here Live webcast registration link: here The conference call will also be broadcast live and available for replay in the investor relations section of the Company's website at About Hallador Energy Company Hallador Energy Company (Nasdaq: HNRG) is a vertically-integrated Independent Power Producer (IPP) based in Terre Haute, Indiana. The Company has two core businesses: Hallador Power Company, LLC, which produces electricity and capacity at its one-Gigawatt (GW) Merom Generating Station, and Sunrise Coal, LLC, which produces and supplies fuel to the Merom Generating Station and other companies. To learn more about Hallador, visit the Company's website at

Hundreds cheer Arizona Sen. Ruben Gallego as Democrats take offensive against Trump's tax bill
Hundreds cheer Arizona Sen. Ruben Gallego as Democrats take offensive against Trump's tax bill

CTV News

time3 hours ago

  • CTV News

Hundreds cheer Arizona Sen. Ruben Gallego as Democrats take offensive against Trump's tax bill

DAVENPORT, Iowa — Hundreds of people cheered Sen. Ruben Gallego at a town hall meeting in eastern Iowa Saturday as the first-term Arizona Democrat assailed the massive, Republican-backed tax bill signed by U.S. President Donald Trump as likely to make 'America poorer and sicker.' Gallego's upbeat event struck the opposite tone from Rep. Mike Flood's town hall meeting earlier in the week, when an even bigger crowd jeered the Nebraska Republican for most of a 90-minute event in his state to promote the bill. Democrats, searching for months after last year's election defeat for footing in opposing the aggressive tone struck by Trump in his second term in the White House, have gone on the offensive this month, still united in their frustration with Trump but suddenly energized in full-throated opposition to his signature legislation. 'I think this bill is helping Democrats see clearly what's at stake with the future of protections for so many regular Americans,' said Pete Wernimont of Waterloo, who drove 140 miles (225 kilometers) to see Gallego. 'I just hope they are there when it really matters a year from now.' While some Republicans in safe Republican districts are braving crowds to sell Trump's law, most in Congress are heeding GOP leaders' suggestion to keep lower public profiles, especially noteworthy during the August recess following closely on Trump's signing of the tax cut and spending reduction bill last month. Democratic activists are rallying to point out what they see as the measure's political liabilities for Republicans trying to hold their narrow majorities in Congress in next year's midterm elections. 'This is the galvanizing moment that's happening because Democrats now understand, we're the people that fight for the middle class and the working class of America,' Gallego told reporters before the event Saturday. 'This is a clarifying moment for us.' For two hours, the audience of some 300 people applauded and at times stood cheering for the Arizona Democrat, one of several party figures who have been attacking the bill in congressional districts represented by Republicans. He was in Rep. Mariannette Miller-Meeks' 1st Congressional District, among the most competitive in the nation in the past three congressional elections. For a party frustrated with an array of Trump administration initiatives, the measure has had its own energizing effect. 'I came here because I work in health care and this bill will hurt health care,' said Alexandra Salter, a physicians assistant from Davenport. 'I think we are getting more vocal about it, because we need to speak up.' The meeting contrasted sharply with Flood's meeting in Lincoln, Nebraska, on Monday, when an even larger crowd of 700 voiced vigorous opposition to the bill, locking in especially on its changes to Medicaid, the federally funded health care program for low-income American. The bill, which passed with no Democratic votes in the House or Senate, makes substantial cuts to the health care program, notably by imposing work requirements for many of those receiving aid. The same frustration that drew Wernimont to Davenport Saturday convinced Ann Ashburn of Aurora, Nebraska, to drive the 70 miles (113 kilometers) to Lincoln to face Flood on Monday. Ashburn learned about Flood's appearance through an Omaha-area Democratic group called Blue Dot and reached out to friends who joined her. She dismissed any suggestion that such opposition had been orchestrated. 'I think the momentum could have been much greater had we been better organized,' the 72-year-old retired executive said. For now, Republicans have their work cut out for them if they hope to use the measure as a reason for voters to return them to the majority in the 2026 elections. About two-thirds of U.S. adults expect the new law will help the rich, according to the poll from The Associated Press-NORC Center for Public Affairs Research. Most — about 6 in 10 — also think it will do more to hurt than help low-income people, according to the survey taken last. Gallego used his trip to Iowa, which included a requisite stop at the Iowa State Fair, to burnish his own profile in a state that, until 2020, traditionally had hosted the first event in the Democrats' presidential nominating process. Iowa Democrats hope to return to the front of the parade when the 2028 primaries and caucuses begin. Other figures already popular nationally with Democrats such as New York Rep. Alexandria Ocasio-Cortez have been making stops in Republican districts decrying the legislation. Ocasio-Cortez last month headlined an event in New York's 21st District, represented by Republican Elise Stefanik, noting among other items its Medicaid provisions. Vermont Sen. Bernie Sanders is scheduled to hold rallies Sunday in Republican-held House districts in North Carolina. He too planned to focus on Medicaid cuts, and note their impact on rural hospitals in the state where former Gov. Roy Cooper, a Democrat now running for U.S. Senate, worked with the GOP-controlled legislature to expand Medicaid coverage in 2023. Thomas Beaumont, The Associated Press

Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025

Globe and Mail

time3 hours ago

  • Globe and Mail

Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025

CAMBRIDGE, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced that management will host a conference call and live audio webcast on Tuesday August 12 th, 2025 at 4:30 p.m. ET to report financial results for second quarter 2025 and provide a business update. To access the call, please dial 1-844-825-9789 (domestic) or 1-412-317-5180 (international) and refer to conference ID 10200686, or click on this link and request a return call with passcode 0605709. The audio webcast can be accessed live on this link and also on the 'Investor Relations' page of the Spero Corporate Website at The archived webcast will also be available on Spero's website for 30 days following the call. About Spero Therapeutics Spero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections with high unmet need. For more information, visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store